Gundlapalli Adi V, Nelson Richard E, Haroldsen Candace, Carter Marjorie E, LaFleur Joanne
Informatics, Decision Enhancement, and Surveillance (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, Utah, United States of America; University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
Informatics, Decision Enhancement, and Surveillance (IDEAS) Center, VA Salt Lake City Health Care System, Salt Lake City, Utah, United States of America; University of Utah College of Pharmacy, Salt Lake City, Utah, United States of America.
PLoS One. 2015 Jul 13;10(7):e0132056. doi: 10.1371/journal.pone.0132056. eCollection 2015.
We describe the rates and predictors of initiation of treatment for chronic hepatitis C (HCV) infection in a large cohort of HCV positive Veterans seen in U.S. Department of Veterans Affairs (VA) facilities between January 1, 2004 and December 31, 2009. In addition, we identify the relationship between homelessness among these Veterans and treatment initiation. Univariate and multivariable Cox Proportional Hazards regression models with time-varying covariates were used to identify predictors of initiation of treatment with pegylated interferon alpha plus ribavirin. Of the 101,444 HCV treatment-naïve Veterans during the study period, rates of initiation of treatment among homeless and non-homeless Veterans with HCV were low and clinically similar (6.2% vs. 7.4%, p<0.0001). For all U.S. Veterans, being diagnosed with genotype 2 or 3, black or other/unknown race, having Medicare or other insurance increased the risk of treatment. Veterans with age ≥50 years, drug abuse, diabetes, and hemoglobin < 10 g/dL showed lower rates of treatment. Initiation of treatment for HCV in homeless Veterans is low; similar factors predicted initiation of treatment. Additionally, exposure to treatment with medications for diabetes predicted lower rates of treatment. As newer therapies become available for HCV, these results may inform further studies and guide strategies to increase treatment rates in all U.S. Veterans and those who experience homelessness.
我们描述了2004年1月1日至2009年12月31日期间在美国退伍军人事务部(VA)设施中就诊的一大群丙型肝炎病毒(HCV)阳性退伍军人中慢性HCV感染治疗起始的发生率及预测因素。此外,我们确定了这些退伍军人中无家可归与治疗起始之间的关系。使用具有随时间变化协变量的单变量和多变量Cox比例风险回归模型来确定聚乙二醇化干扰素α加利巴韦林治疗起始的预测因素。在研究期间的101,444名未经HCV治疗的退伍军人中,无家可归和有家可归的HCV退伍军人的治疗起始率较低且临床上相似(6.2%对7.4%,p<0.0001)。对于所有美国退伍军人,被诊断为基因2型或3型、黑人或其他/未知种族、拥有医疗保险或其他保险会增加治疗风险。年龄≥50岁、药物滥用、糖尿病和血红蛋白<10 g/dL的退伍军人治疗率较低。无家可归退伍军人的HCV治疗起始率较低;相似的因素可预测治疗起始。此外,使用糖尿病药物治疗与较低的治疗率相关。随着针对HCV的新疗法问世,这些结果可能为进一步研究提供参考,并指导提高所有美国退伍军人以及无家可归者治疗率的策略。